Trials / Completed
CompletedNCT00276354
Study of Long-term Use of Forlax® in Elderly Patients With Chronic Constipation
Tolerance of Long Term Administration of Forlax® 10g in Elderly Ambulatory or Institutionalized Patients Suffering From Chronic Constipation. Single Blind Randomised Lactulose-controlled Study With Individual Expected Benefit.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 246 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the tolerance of long term repeated doses of Forlax® 10g versus lactulose in elderly ambulatory or institutionalized patients, paying special attention to digestive and nutritional status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG 4000 (Forlax ®) |
Timeline
- Start date
- 1999-12-01
- Completion
- 2001-11-20
- First posted
- 2006-01-13
- Last updated
- 2019-07-26
Locations
146 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00276354. Inclusion in this directory is not an endorsement.